Filing Details
- Accession Number:
- 0001209191-20-023673
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-06 20:08:54
- Reporting Period:
- 2020-04-02
- Accepted Time:
- 2020-04-06 20:08:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1468748 | Kodiak Sciences Inc. | KOD | Biological Products, (No Disgnostic Substances) (2836) | 270476525 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1754627 | Hong Liang | 2631 Hanover St. Palo Alto CA 94304 | Svp, Discovery Medicine | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-04-02 | 4,000 | $42.34 | 130,166 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.
- The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $41.97 to $42.71, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.